Optiver Holding
OBIO icon

Optiver Holding’s Orchestra BioMed OBIO Stock Holding History

Optiver Holding’s Portfolio OBIO Stock Details OBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$173 Buy
+40
New +$164 ﹤0.01% 2622
2026
Q1 		– Sell
-312
Closed -$1.29K – 2618
2025
Q4 		$1.29K Hold
312
– – ﹤0.01% 2161
2025
Q3 		$774 Buy
+312
New +$861 ﹤0.01% 2528

Other funds holding OBIO

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Optiver Holding's OBIO Position: Q2 2026 in Review

Optiver Holding opened a new position in Orchestra BioMed (OBIO) in Q2 2026: 40 shares worth $173. The stake represents ﹤0.01% of the portfolio and ranks #2622 among its holdings. This is a return to the name: Optiver Holding previously reported a position in OBIO as recently as Q4 2025.

Optiver Holding first reported a position in OBIO in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.29K in Q4 2025. 77 funds tracked by Wall St. Rank hold OBIO as of Q2 2026.

  • Optiver Holding held 40 shares of Orchestra BioMed worth $173 as of Q2 2026.
  • Orchestra BioMed was a new Optiver Holding position in Q2 2026.
  • Orchestra BioMed made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2622 holding.
  • Optiver Holding first reported a position in Orchestra BioMed in Q3 2025 and has held it in 3 quarters since.
  • Optiver Holding's Orchestra BioMed position peaked at $1.29K in Q4 2025.
  • 77 funds tracked by Wall St. Rank held Orchestra BioMed as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.